NCT03031210View on ClinicalTrials.gov

Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

1,370

Participants

Timeline

Start Date

June 11, 2017

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions

Community-acquired Pneumonia

Interventions

DRUG

Amoxicillin

(90 mg/kg/day) twice daily

Trial Locations (1)

H3T1C5

RECRUITING

CHU Sainte-Justine, Montreal

All Listed Sponsors

lead

St. Justine's Hospital

OTHER